WHO classification

The World Health Organisation (WHO) defines obesity as a body mass index (BMI) greater than or equal to 30 kg/m, where BMI is calculated as weight in kilogram divided by the square of height in metre. Table 7.1 shows the WHO classification in full. BMI is a simple index of obesity and correlates well with total adiposity, morbidity and mortality from many diseases. ... 

Lymphoid neoplasms in both the REAL and the WHO classifications are defined as specific entities based on morphology, immunophenotype, genotype, and clinical characteristics (HI 1, J2). These neoplastic entities, however, tend to mimic their... 

Bacher U, Kern W, Schnittger S, Hiddemann W, Schoch C, Haferlach T. Further correlations of morphology according to FAB and WHO classification to cytogenetics in de novo acute myeloid leukemia A study on 2,235 patients. Ann Hematol 2005 84(12) 785—791. 

WHO Classification WHO II - Moderately Hazardous Chemical Croup Organochlorine ... 

Table 2.2 WHO Classification of Xerophthalmia Classification Code Clinical Description Prevalence among Preschool Children to Indicate Significant Public Health Problems...

Tatter SB 2005. The new WHO classification of tumors affecting the human central nervous system. http //neurosurgery.mgh.harvard.edU/newwhobt.htm Mutations Tentori L, Graziani G (2009) Recent approaches to improve the antitumor efficacy of temozolo-mide. Curr Med Chem 16 245-257... 

The following sections consider the most important drugs that have the potential to affect the eye. Where possible, the WHO Classification for Causality is Usted for each sign or symptom. Where available, a brief explanation of the etiology is provided and the management strategy for the OADR is discussed. 

OADR (including WHO classification of causality, where available)... 

Vardiman JW, Harris NL, Bmnning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 2002 100 2292-302. 

The current classification system for non-Hodgkin s lymphoma is the Revised European-American Classification of Lymphoid Neoplasms and World Health Organization (REAL-WHO) classification system, which is based on the principle that a classification is a list of specific disease entities defined by a combination of morphology, immunophe-notype, genetic features, and clinical features. 

Since 1995, members of the European and American hematopathology societies have worked to develop a new WHO classification of hematologic malignancies. The final classification was published in 2001. The WHO classification uses an updated version of the REAL classification and expands the principles of the REAL classification to the classification of myeloid and histiocytic malignancies. 

---